BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15631637)

  • 1. Increased expression of integrin-linked kinase is associated with shorter survival in non-small cell lung cancer.
    Takanami I
    BMC Cancer; 2005 Jan; 5():1. PubMed ID: 15631637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-related genes.
    Chen D; Zhang Y; Zhang X; Li J; Han B; Liu S; Wang L; Ling Y; Mao S; Wang X
    Acta Histochem; 2013 Mar; 115(2):128-36. PubMed ID: 22683084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival.
    Dai DL; Makretsov N; Campos EI; Huang C; Zhou Y; Huntsman D; Martinka M; Li G
    Clin Cancer Res; 2003 Oct; 9(12):4409-14. PubMed ID: 14555513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Catulin drives metastasis by activating ILK and driving an αvβ3 integrin signaling axis.
    Liang CH; Chiu SY; Hsu IL; Wu YY; Tsai YT; Ke JY; Pan SH; Hsu YC; Li KC; Yang PC; Chen YL; Hong TM
    Cancer Res; 2013 Jan; 73(1):428-38. PubMed ID: 23047866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer.
    Shah A; Swain WA; Richardson D; Edwards J; Stewart DJ; Richardson CM; Swinson DE; Patel D; Jones JL; O'Byrne KJ
    Clin Cancer Res; 2005 Apr; 11(8):2930-6. PubMed ID: 15837744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
    Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F; Dosaka-Akita H; Mishina T; Nishi M; Kojima T; Hiroumi H; Ogura S; Shimizu M; Katoh H; Kawakami Y
    Clin Cancer Res; 2000 Oct; 6(10):4073-81. PubMed ID: 11051259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer.
    Müller-Tidow C; Metzger R; Kügler K; Diederichs S; Idos G; Thomas M; Dockhorn-Dworniczak B; Schneider PM; Koeffler HP; Berdel WE; Serve H
    Cancer Res; 2001 Jan; 61(2):647-53. PubMed ID: 11212263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of maspin in non-small-cell lung cancer: correlation with clinical features.
    Takanami I; Abiko T; Koizumi S
    Clin Lung Cancer; 2008 Nov; 9(6):361-6. PubMed ID: 19073519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
    Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
    Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
    Li L; Mei TH; Zhou XD; Zhang XG
    Ai Zheng; 2009 Jan; 28(1):60-3. PubMed ID: 19448419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
    Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
    Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
    Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis.
    Dosaka-Akita H; Hommura F; Mishina T; Ogura S; Shimizu M; Katoh H; Kawakami Y
    Cancer Res; 2001 Mar; 61(6):2500-4. PubMed ID: 11289121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients.
    Kato T; Daigo Y; Aragaki M; Ishikawa K; Sato M; Kondo S; Kaji M
    Lung Cancer; 2011 Oct; 74(1):124-31. PubMed ID: 21376419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic fibroblast growth factor-2/beta3 integrin expression profile: signature of local progression after chemoradiotherapy for patients with locally advanced non-small-cell lung cancer.
    Massabeau C; Rouquette I; Lauwers-Cances V; Mazières J; Bachaud JM; Armand JP; Delisle MB; Favre G; Toulas C; Cohen-Jonathan-Moyal E
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):696-702. PubMed ID: 19386436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
    Takanami I
    Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.